Clinical Trials Browser

Phase 1/2 × tetrathiomolybdate × Clear all

NCT06134375 2026-03-12

A Study of Tetrathiomolybdate (TM) Plus Capecitabine

Phase 1/2 Recruiting

Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT00352742 2008-10-28

A Study of ATN-224 and Bortezomib in Patients With Multiple Myeloma

Phase 1/2 Terminated

Multiple Myeloma, Recurrence